These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19939703)

  • 21. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.
    Ishikawa A; Motohashi S; Ishikawa E; Fuchida H; Higashino K; Otsuji M; Iizasa T; Nakayama T; Taniguchi M; Fujisawa T
    Clin Cancer Res; 2005 Mar; 11(5):1910-7. PubMed ID: 15756017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.
    Kim HY; Pichavant M; Matangkasombut P; Koh YI; Savage PB; DeKruyff RH; Umetsu DT
    J Immunol; 2009 Mar; 182(5):3252-61. PubMed ID: 19234223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate IFN-gamma production by subsets of natural killer cells, natural killer T cells and gammadelta T cells in response to dying bacterial-infected macrophages.
    Kubota K
    Scand J Immunol; 2010 Mar; 71(3):199-209. PubMed ID: 20415785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    Clin Immunol; 2001 Jan; 98(1):70-84. PubMed ID: 11141329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
    Lynch L; O'Shea D; Winter DC; Geoghegan J; Doherty DG; O'Farrelly C
    Eur J Immunol; 2009 Jul; 39(7):1893-901. PubMed ID: 19585513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer.
    Takami M; Ihara F; Motohashi S
    Front Immunol; 2018; 9():2021. PubMed ID: 30245690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
    Cullen R; Germanov E; Shimaoka T; Johnston B
    J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS; Chiu B; Na KS; Inman RD
    Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of leukotriene B4 12-hydroxydehydrogenase in α-galactosylceramide-pulsed dendritic cell therapy for non-small cell lung cancer.
    Tanaka K; Kanesaka Y; Takami M; Suzuki A; Hosokawa H; Onodera A; Kamata T; Nagato K; Nakayama T; Yoshino I; Motohashi S
    Biochem Biophys Res Commun; 2018 Nov; 506(1):27-32. PubMed ID: 30336981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
    J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the cytokine profiles produced by invariant natural killer T cells in the initial phase of cyclophosphamide-induced tolerance.
    Onzuka T; Tomita Y; Shimizu I; Okano S; Yamada H; Yoshikai Y; Tominaga R
    Transplantation; 2008 Nov; 86(9):1301-10. PubMed ID: 19005413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.
    Gu T; Kilinc MO; Egilmez NK
    Cancer Immunol Immunother; 2008 Jul; 57(7):997-1005. PubMed ID: 18049819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.
    Lindqvist M; Persson J; Thörn K; Harandi AM
    J Immunol; 2009 May; 182(10):6435-43. PubMed ID: 19414797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
    J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
    Bontkes HJ; Moreno M; Hangalapura B; Lindenberg JJ; de Groot J; Lougheed S; van der Vliet HJ; van den Eertwegh AJ; de Gruijl TD; von Blomberg BM; Scheper RJ
    Clin Immunol; 2010 Sep; 136(3):364-74. PubMed ID: 20570567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma.
    Raez LE; Cassileth PA; Schlesselman JJ; Padmanabhan S; Fisher EZ; Baldie PA; Sridhar K; Podack ER
    Cancer Gene Ther; 2003 Nov; 10(11):850-8. PubMed ID: 14605671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
    Ramanathapuram LV; Kobie JJ; Bearss D; Payne CM; Trevor KT; Akporiaye ET
    Cancer Immunol Immunother; 2004 Jul; 53(7):580-8. PubMed ID: 14991239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation or anergy: NKT cells are stunned by alpha-galactosylceramide.
    Sullivan BA; Kronenberg M
    J Clin Invest; 2005 Sep; 115(9):2328-9. PubMed ID: 16138189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
    Fujii S
    Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.